pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,883 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07521787: Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery

Sponsor: Shanghai Zhongshan Hospital. Phase: . Conditions: Cardiac Surgery Associated - Acute Kidney Injury, Critical Illness

full page →ctgov ↗
›TERMINATEDphase readoutNCT05814666: Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC

Sponsor: Flamingo Therapeutics NV. Phase: PHASE2. Conditions: HNSCC

full page →ctgov ↗
›RECRUITINGphase readoutNCT06561451: Live Birth Rate Between ICSI and AOA and ICSI Alone in Patients With Severe Teratospermia

Sponsor: ShangHai Ji Ai Genetics & IVF Institute. Phase: NA. Conditions: Male Infertility, Teratospermia

full page →ctgov ↗
›COMPLETEDphase readoutNCT02793453: Antimicrobial Peptides in Periodontitis

Sponsor: CHU de Reims. Phase: NA. Conditions: Periodontal Disease : Chronic Periodontitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07302802: Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

Sponsor: Prof. Dr. Martin Wabitsch. Phase: . Conditions: Monogenic Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT04984837: Study of Lacutamab in Peripheral T-cell Lymphoma

Sponsor: The Lymphoma Academic Research Organisation. Phase: PHASE2. Conditions: Peripheral T Cell Lymphoma, Relapse/Recurrence

full page →ctgov ↗
›RECRUITINGphase readoutNCT06362837: Evaluation of REACTS-IN, an Intervention to Improve Nutrition, Hygiene, and Sexual and Reproductive Health Services

Sponsor: McGill University. Phase: NA. Conditions: Stunting, Gender Equality, Acceptability of Health Care, Diet; Deficiency, Empowerment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07444645: PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Tumor, Liver

full page →ctgov ↗
›COMPLETEDphase readoutNCT07495345: Feasibility Study of a Novel Automated Slit Lamp Camera (Lightfield Medical Ophthalmic Camera Model Vscan001)

Sponsor: Lightfield Medical. Phase: NA. Conditions: Anterior Segment of Eye

full page →ctgov ↗
›RECRUITINGphase readoutNCT07203339: Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine: Non-inferiority Clinical Trial (FIBROSTIM)

Sponsor: Hospital de Clinicas de Porto Alegre. Phase: NA. Conditions: Fibromyalgia (FM), tDCS, Duloxetine, BDNF, EEG

full page →ctgov ↗
›COMPLETEDphase readoutNCT04217239: A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy

Sponsor: The Second Hospital of Shandong University. Phase: NA. Conditions: Esophageal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06232577: 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Intra-abdominal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03520101: Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses. The 'LYTEN' Trial

Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec. Phase: NA. Conditions: Aortic Valve Stenosis, Regurgitation, Aortic, Prosthesis Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT06618781: Perioperative Effects of Lateral Quadratus Lumborum Block in Percutaneous Transhepatic Cholangiography

Sponsor: Ankara Etlik City Hospital. Phase: NA. Conditions: Opioid Consumption, Visual Analog Score, Demographic Data, Rescue Analgesic Status and Time

full page →ctgov ↗
›COMPLETEDphase readoutNCT07279181: TVS, SHG, and MRI in Uterine Niche

Sponsor: International Peace Maternity and Child Health Hospital. Phase: . Conditions: Uterine Niche

full page →ctgov ↗
›RECRUITINGphase readoutNCT05708430: Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis

Sponsor: University Hospital, Rouen. Phase: PHASE2. Conditions: Rhizarthrosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03166930: Evaluation of a Spasticity Management Program for People With Multiple Sclerosis

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06712628: A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

Sponsor: AbbVie. Phase: . Conditions: Moderate to Severe Rheumatoid Arthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07525765: AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: . Conditions: Gastrectomy for Gastric Cancer, Gastric Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06409065: Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07032571: Reset: Enhancing Weight Loss in a Digital Intervention

Sponsor: Stanford University. Phase: NA. Conditions: Obesity, Overweight, Weight Loss, Health Behavior, Lifestyle Intervention

full page →ctgov ↗
›RECRUITINGphase readoutNCT07343271: Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx

Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07364071: Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer

Sponsor: University of California, San Diego. Phase: PHASE2. Conditions: Prostate Adenocarcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05892744: Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

Sponsor: University of Texas at Austin. Phase: PHASE4. Conditions: Major Depressive Disorder, Chronic Major Depression, Recurrent

full page →ctgov ↗
›COMPLETEDphase readoutNCT06254144: Neuroimaging Study for Decoding Emotional States and Identifying Neural Circuits to Disengage From Negative Thinking

Sponsor: Laureate Institute for Brain Research, Inc.. Phase: . Conditions: Depressive Disorder, Major

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07432009: Orthopedic Procedures and Postoperative Delirium in Older Adults in the Czech Republic

Sponsor: Tomas Bata Hospital, Czech Republic. Phase: . Conditions: Frailty, Cognitive Impairment, Older Adults, Hip Arthroplasty, Postoperative Delirium

full page →ctgov ↗
›COMPLETEDphase readoutNCT00003809: Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Sponsor: Eastern Cooperative Oncology Group. Phase: PHASE3. Conditions: Head and Neck Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07544199: Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders

Sponsor: IRCCS Eugenio Medea. Phase: . Conditions: Neurodevelopmental Disorder (Diagnosis)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04334031: Deployment o the Multidisciplinary Prospective Cohort Imminent

Sponsor: University Hospital, Lille. Phase: NA. Conditions: Chronic Inflammatory Disease, Angioedema, Severe Asthma, Lupus, Atopic Dermatitis, Psoriatic Arthritis, Multiple Sclerosis, Systemic Sclerosis, Behçet Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT02577731: Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury

Sponsor: University of Florida. Phase: NA. Conditions: Trauma Injury

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04903002: Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain

Sponsor: Memorial University of Newfoundland. Phase: PHASE2. Conditions: Chronic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06915337: Magnet Anastomosis in Patients Undergoing Gastric Surgery

Sponsor: GI Windows, Inc.. Phase: NA. Conditions: Gastric Anastomosis (Site)

full page →ctgov ↗
›COMPLETEDphase readoutNCT03439137: Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan

Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Anemia; Hemodialysis Dependent Chronic Kidney Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05642572: Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network. Phase: PHASE2. Conditions: Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8

full page →ctgov ↗
›TERMINATEDphase readoutNCT06110195: Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

Sponsor: University of Chicago. Phase: PHASE1. Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck

full page →ctgov ↗
›RECRUITINGphase readoutNCT07338539: BIO-SHORT: Biologically Guided Short-Course Hypofractionated RT for Poor-Prognosis GBM

Sponsor: Tata Memorial Centre. Phase: PHASE2. Conditions: Glioma

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06701175: Knee Arthroscopy for Pain Control

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Knee Arthroscopy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06333457: Presence and Relapse Rates in Patients With Alcohol Use Disorder Using Virtual Reality

Sponsor: Charite University, Berlin, Germany. Phase: . Conditions: Alcohol Dependence

full page →ctgov ↗
›RECRUITINGphase readoutNCT03980457: Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke

Sponsor: University of Oklahoma. Phase: NA. Conditions: Stroke, Weakness of Extremities as Sequela of Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07395401: Evaluation of Zinc Oxide Eugenol and Iodoform-Calcium Hydroxide as Filling Materials in Primary Molar Root Canals Prepared by Rotary and Manual Files

Sponsor: October University for Modern Sciences and Arts. Phase: NA. Conditions: Carious Primary Molars Indicated for Pulpectomy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07465081: Ultra-processed Food Consumption and Behavioral Disorder and Cognitive Function

Sponsor: China Medical University Hospital. Phase: NA. Conditions: ADD/ADHD

full page →ctgov ↗
›RECRUITINGphase readoutNCT07392281: Efficacy and Mechanisms of Macitentan for Non-Coronary Obstructive Angina

Sponsor: China-Japan Friendship Hospital. Phase: EARLY_PHASE1. Conditions: Non-Coronary Obstructive Angina

full page →ctgov ↗
›RECRUITINGphase readoutNCT06395181: Whole Food Plant-based Diet Effect on Obstructive Sleep Apnea

Sponsor: Mayo Clinic. Phase: NA. Conditions: Obstructive Sleep Apnea, Daytime Sleepiness

full page →ctgov ↗
›COMPLETEDphase readoutNCT03190681: Motivation and Methylphenidate

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: EARLY_PHASE1. Conditions: Motivation, Apathy, Impulsive Behavior

full page →ctgov ↗
›RECRUITINGphase readoutNCT06589128: Efficacy of Investigator Product for the Amelioration of Digital Eye Strain in Children

Sponsor: Universiti Sains Malaysia. Phase: NA. Conditions: Digital Eye Strain (DES)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06091228: The Additional Effect of Tongue Scraping on Halitosis Parameters in Initial Periodontal Therapy

Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: NA. Conditions: Periodontitis, Halitosis, Tongue Condition

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05025800: ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, Ann Arbor Stage III Marginal Zone Lymphoma, Ann Arbor Stage IV Grade 1 Follicular Lymphoma, Ann Arbor Stage IV Grade 2 Follicular Lymphoma, Ann Arbor Stage IV Grade 3 Follicular Lymphoma, Ann Arbor Stage IV Marginal Zone Lymphoma, Composite Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Refractory Aggressive B-Cell Non-Hodgkin Lymphoma, Refractory Follicular Lymphoma, Refractory Grade 3b Follicular Lymphoma, Refractory High Grade B-Cell Lymphoma, Refractory Mantle Cell Lymphoma, Refractory Marginal Zone Lymphoma, Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma, Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma, Richter Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07480200: Effect of Trigger Point Cryostimulation on Exercise-Induced Tremor in Adolescent Swimmers

Sponsor: Józef Piłsudski University of Physical Education. Phase: NA. Conditions: Physiological Tremor, Exercise-Induced Neuromuscular Fatigue

full page →ctgov ↗
›RECRUITINGphase readoutNCT07455292: Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging

Sponsor: IRCCS Policlinico S. Donato. Phase: NA. Conditions: Left Ventricle Function, Transcatheter Aortic Valve Replacement (TAVR), Aortic Valve Stenosis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT04886492: CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

Sponsor: CorEvitas. Phase: . Conditions: Neuromyelitis Optica Spectrum Disorder

full page →ctgov ↗
← prev
page 72 of 158
next →